SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PMN Promis Neurosciences is trying to Design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might be on to somethin

PMN Promis Neurosciences is trying to Design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might be on to something - STAT News Link To Story from STATNEWS.com; shares+10% premarket

PMN

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.